Dr. Alana Lee Grajewski, MD

Dr. Grajewski practices at Lucile Packard Children's Hospital Stanford in Palo Alto, California, part of Stanford University.

Dr. Grajewski's NPI, 1538187588, was assigned on July 18, 2006. Dr. Grajewski graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1983. Dr. Grajewski holds Florida license ME50567.

Dr. Grajewski's primary practice is Lucile Packard Children's Hospital Stanford, at 725 Welch Road, Palo Alto, CA 94304 in Santa Clara County. The practice phone is (650) 497-8000.

Dr. Grajewski's primary practice is Lucile Packard Children's Hospital Stanford in Palo Alto, California, part of Stanford University. Dr. Grajewski is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Grajewski to 1 more hospital and 4 medical groups, each named with a free account. Dr. Grajewski's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grajewski practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Grajewski's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Grajewski is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Grajewski's licenses on file in 5 states: Florida, New Jersey, California, Minnesota and Pennsylvania.

Dmand AI lists cataract, glaucoma, glaucoma surgery and hypertensive retinopathy among the conditions Dr. Grajewski treats.

CMS data shows 81 Medicare services from Dr. Grajewski across 1 procedure code in 2023, all of them office visits. Medicare paid $5,997 for them.

Across all payers, Dmand AI patient panel data puts Dr. Grajewski's median patient age at 53, with 54% women.

In 2024, Dr. Grajewski wrote 109 Medicare Part D claims for 51 patients. 69% of them were for generic drugs. CMS names the drug for 53 of them, across 3 drugs with 11 or more claims each, at $774 in total drug cost. In 2023, CMS named 694 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Grajewski for performance year 2024, reported as part of a group. Dr. Grajewski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 63 papers to Dr. Grajewski, published from 2009 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Glaucoma, Intraocular Pressure and Trabeculectomy. Dr. Grajewski has published most often in J Glaucoma. Dr. Grajewski's most frequent co-authors are Ta Chen Peter Chang, MD, Elizabeth Ann Hodapp, MD and Elena Bitrian, MD.

Dmand AI links Dr. Grajewski to 1 clinical trial. Conditions studied include Glaucoma and Ocular Hypertension.

CMS Open Payments shows 19 general payments to Dr. Grajewski from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Sight Sciences, Inc. paid the most, $520.

Dmand AI lists 2 awards for Dr. Grajewski, most recently CMS Stage 1 EHR in 2014.

Dr. Grajewski graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 1983.

Dr. Grajewski is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.